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Trafﬁckinga b s t r a c t
Intercellular communication can occur through gap junction channels, which are comprised of
connexin proteins. Therefore, levels of connexins can directly correlate with gap junctional intercel-
lular communication. Because gap junctions have a critical role in maintaining cellular homeostasis,
the regulation of connexin protein levels is important. In the connexin life cycle, connexin protein
levels can be modiﬁed through differential gene transcription or altered through trafﬁcking and
degradation mechanisms. More recently, signiﬁcant attention has been directed to the pathways
that cells utilize to increase or decrease connexin levels and thus indirectly, gap junctional commu-
nication. Here, we review the studies revealing the mechanisms that affect connexin protein levels
and gap junctional intercellular communication.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction four transmembrane domains that are linked by one intracellularCellular processes are regulated, in part, by the interaction
between cells. One important mode of interaction between
neighboring cells is mediated by gap junction channels, which
provide a direct conduit between the cytoplasms of adjacent cells.
Gap junctions allow the transfer of small molecules up to
1000 daltons in size. Transferred molecules include secondary
messengers, small metabolites, and ions [1,2]. Gap junctional inter-
cellular communication (GJIC) is critical during both development
and adult stages in maintaining homeostasis [3–5]. Alterations in
GJIC can result in a host of human diseases, such as cancer [6],
heart disease [7–9], and developmental diseases [10].
Gap junction channels are comprised of integral multi-pass
transmembrane proteins called connexins [1,2]. Connexins haveloop, two extracellular loops, and have N- and C-terminal cytoplas-
mic domains. Connexin hexamers, called connexons or hemichan-
nels, are formed in the secretory pathway. The hemichannels are
then trafﬁcked to the cell surface where they can act as stand-alone
channels, or dock with hemichannels in appositional membranes
to form intact gap junctions. There are 21 members of the human
connexin protein family and 20 mouse connexins. Of these, conn-
exin43 (Cx43) is the most ubiquitously expressed and the most
widely studied.
Connexins have a short half-life of 1.5–5 h, compared to other
transmembrane proteins [11–15]. For this reason, the regulation
of connexin protein levels and connexin trafﬁcking can potentially
have a critical effect on the level of GJIC. Connexin levels can also
have an effect on hemichannel functions, which have more
recently been demonstrated to have important roles in cell death
and tissue remodeling [16]. This review will focus on recent ﬁnd-
ings on the pathways and mechanisms mediating Cx43 trafﬁcking
and degradation.
2. Secretory pathway and proteasomal degradation
Connexins are thought to be co-translationally inserted into the
endoplasmic reticulum (ER) membrane, and properly folded in the
Fig. 1. Model for the CIP75-mediated proteasomal degradation of Cx43. Cx43 is
co-translationally inserted into the ER where it is properly folded, then transported
to the Golgi for oligomerization and transport to the plasma membrane. When
Cx43 misfolding is induced, by ER stress for example, CIP75 interacts with the
cytoplasmic C-terminal domain of Cx43 and facilitates the interaction of Cx43 with
and subsequent degradation by the proteasome.
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connexin protein misfolding, connexins will undergo degradation
by the proteasome [15,17], the cellular organelle generally respon-
sible for the ‘‘clean-up’’ of misfolded proteins. The proteasome is a
26S holoenzyme complex comprised of 2 major subunits, the 20S
core and the 19S cap or regulatory particles which are each made
up of multiple individual protein subunits [18]. ER-associated
degradation (ERAD) is the process responsible for the removal
and proteasomal degradation of misfolded proteins localized to
the ER. During ERAD, misfolded proteins in the ER are recognized
by a molecular chaperone such as Bip, transported out of the ER
through the retrotranslocon channel into the cytoplasm to be
degraded by the proteasome [19].
Connexin proteasomal degradation was ﬁrst demonstrated with
Cx43, in Chinese hamster ovary (CHO) E36 and rat heart-derived
BWEM cells [20]. Upon treatment of these cells with the proteaso-
mal inhibitor, ALLN, Cx43 levels were increased, and correspond-
ingly, turnover was reduced. Studies with ALLN and another
proteasomal inhibitor, lactacystin, in neonatal rat ventricular myo-
cytes, demonstrated that blocking proteasomal degradation
reduced the loss of Cx43 that was induced by heat treatment
[21], which conﬁrmed further that Cx43 undergoes proteasomal
degradation. ERAD-mediated degradation of Cx43 was also demon-
strated in response to protein misfolding. ER stress to induce Cx43
misfolding (i.e. DTT treatment to break the disulﬁde bonds present
in the Cx43 extracellular loops) in CHO and mouse S180 cells, pro-
moted the dislocation of Cx43 from the ER into the cytosol and
subsequently resulted in proteasomal degradation, as indicated
by increased Cx43 protein levels after treatment with the protea-
somal inhibitors ALLN, epoxomicin, or ZL3VS [15,17]. In addition,
siRNA-induced down-regulation of the ER resident chaperone
ERp29 (a thioredoxin family protein that promotes protein folding
and trafﬁcking) decreased the total amount of exogenously
expressed Cx43 in HeLa cells and increased the rate of Cx43 turn-
over as evidenced by a diminished half-life of 2.2 h compared to
4 h in control cells [22]. Lactacystin treatment restored the levels
of Cx43 in the siRNA-treated ERp29 cells, conﬁrming the role of
proteasomal degradation in the turnover of misfolded Cx43 [22].
Our laboratory identiﬁed a novel interaction between Cx43
and CIP75 [23], a protein that belongs to the ubiquitin-like (UbL)
and ubiquitin-associated (UBA) domain family. This protein
family, via the UbL domain, is able to interact with subunits in
the proteasome 19S regulatory particle, speciﬁcally the Rpn1/S2
and Rpn10/S5a proteins [24]. UbL–UBA proteins have been
demonstrated to facilitate the proteasomal degradation of other
substrates. For example, Rad23 promotes the degradation of the
p53 tumor suppressor [25,26] and the CDK inhibitor Sic1 [27].
The ubiquitin-interacting UBA domain is the primary region sup-
porting the interaction with the protein substrates. We have found
that CIP75 is similarly able to interact with the Rpn1 and Rpn10
proteasomal proteins via its UbL domain, and with Cx43 via the
UBA domain [23]. Both domains are necessary for facilitating
Cx43 proteasomal degradation [23]. Recently, we have discovered
that CIP75 mediates the degradation of misfolded Cx43 located in
the ER, as the induction of protein misfolding by DTT treatment of
HeLa cells expressing ER-localized Cx43 increased the CIP75–Cx43
interaction [28]. The interaction of Cx43 with the proteasomal sub-
unit Rpn1 also increased with treatment, but this was dependent
on CIP75 as the shRNA knockdown of CIP75 prevented the DTT-
induced increase in Cx43–Rpn1 interaction [28], which indicated
that CIP75 is essential for bridging Cx43 with the proteasome
under conditions of ER stress.
Proteins bound for proteasomal degradation are typically
marked with covalently attached polyubiquitin chains. These are
thought to be lysine48 (K48)-linked tetraubiquitin chains.
Ubiquitination is a multi-step process catalyzed by a cascade ofubiquitin-conjugating enzymes [29]. The evolutionarily-conserved
76-amino acid ubiquitin protein is ﬁrst activated by the E1 ubiqui-
tin-activating enzyme. Activated ubiquitin is then transferred to
one of multiple E2 ubiquitin-conjugating enzymes that associate
with an E3 ubiquitin ligase. This multimeric complex results in
the covalent bonding of the ubiquitin protein with either the sub-
strate target protein or, during the generation of a polyubiquitin
chain, with another ubiquitin moiety at lysine residues. The ubiq-
uitination of Cx43 has previously been demonstrated [20,30,31];
however, it is unclear whether ubiquitination is a necessary prere-
quisite for Cx43 proteasomal degradation. Although ubiquitinated
Cx43 at the plasma membrane has been detected [30,32–34], the
pool of Cx43 bound for ERAD has not been speciﬁcally assessed
for ubiquitination. In our studies, we utilized Cx43 point mutants
where lysine residues were mutated to arginine to prevent poten-
tial Cx43 ubiquitination [35]. We observed that CIP75 still inter-
acted with the ubiquitin-deﬁcient Cx43 mutants, revealing a rare
situation where the ubiquitination of Cx43 is not an absolute
requirement for ERAD. It is important to note that our studies
did not eliminate the possibility that the pool of proteasomally-de-
graded Cx43 is at least partially ubiquitinated [35]. Based on our
observations, we have proposed that CIP75 is required to mediate
the proteasomal degradation of non-ubiquitinated ER-localized
Cx43 by facilitating its interaction with the proteasome (Fig. 1).
3. Connexin internalization and intracellular trafﬁcking
3.1. Endocytosis
After connexins are translated and properly folded in the ER,
connexons are assembled from the connexin subunits either in
the ER-Golgi intermediate compartment (ERGIC) or in the Golgi
apparatus. These hexameric connexons can be formed from either
the same connexin protein (homomeric) or different connexins
(heteromeric). Connexons or hemichannels are then trafﬁcked to
the plasma membrane where they can dock with appositional con-
nexons, via the disulﬁde bonds located in the extracellular loops.
Connexons can dock with connexons formed from the same con-
nexins (homotypic) or from different connexins (heterotypic).
The docked connexons between adjacent cells form a complete
gap junction channel. Large areas of docked connexons are termed
plaques. It is generally thought that connexons are delivered to the
periphery of the plaques and migrate laterally to the center of the
plaque. Older gap junctions are removed from the center of the
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called connexosomes or annular gap junctions (AGJs) that are
subsequently degraded [36–38].
The level of GJIC is known to be regulated by multiple mecha-
nisms- two of the major mechanisms are phosphorylation and
endocytosis. Numerous studies have revealed the role of phosphor-
ylation of various tyrosine and serine residues in the Cx43 C-termi-
nal cytoplasmic domain in mediating channel opening and closing
(reviewed in [39,40]). The endocytosis of gap junctions serves to
physically remove channels from the plasma membrane, in effect
reducing the amount of GJIC. Cx43 has been observed to colocalize
with markers of endosomal compartments, such as EEA1, Rab5,
and Rab7 [33,41–45]. Gap junction internalization has been
explored with immense interest and great strides have been made
in elucidating the mechanisms that regulate gap junction
endocytosis.
3.2. Clathrin-mediated endocytosis
Clathrin-mediated endocytosis (CME) has been found to play an
integral role in gap junction internalization. Time-lapse studies of
Cx43-GFP exogenously expressed in HeLa cells found internalized
AGJs, which appeared to form from large areas of gap junction pla-
ques. The larger AGJs were also observed to fragment into smaller
AGJs [46]. Clathrin colocalized with Cx43-GFP at gap junction pla-
ques and in the internalized AGJs. Furthermore, the formation of
AGJs was dependent on clathrin, as the reduction of clathrin levels
by siRNA signiﬁcantly reduced the amount of internalized AGJs,
which was similar to the effect resulting from the inhibition of
CME by the treatment of the cells with hypertonic medium [46].
The clathrin adaptor proteins, AP-2 and Disabled-2 (Dab2), as well
as the GTPase dynamin2 (Dyn2), which mediates the budding of
vesicles from the membrane, were also found to colocalize with
Cx43 gap junctions and AGJs [46]. Similar to clathrin, siRNA knock-
down of these three proteins also signiﬁcantly reduced the
amounts of internalized Cx43 AGJs [47]. Dyn2 GTPase activity
was speciﬁcally found to be important because the expression of
the dominant-negative Dyn2K44A mutant and use of the dynasore,
an inhibitor of dynamin, also reduced the internalization of Cx43 in
AGJs [47,48].
Clathrin does not interact directly with the cargo found in the
clathrin-coated vesicles formed during CME. Instead, cargo is rec-
ognized by adaptor proteins which recruit CME machinery to facil-
itate the endocytosis. As previously described, AP-2 and Dab2
colocalized with Cx43 and several experiments helped to identify
AP-2 as a Cx43 binding protein. First, a C-terminal tyrosine-based
sorting motif (YXXU), Y286KLV, in Cx43 was identiﬁed as an impor-
tant signal for Cx43 degradation. The Cx43Y286A and Cx43V289D
mutants were expressed at elevated total levels compared to the
wild-type control or other point mutations in the nearby region
(G285A and P283L) [49]. Second, yeast two-hybrid analysis
revealed the direct interaction between the C-terminal domain of
Cx43 with the l2 subunit of the AP-2 adaptor protein complex,
which was abolished in the Y286A, V289D, and Y286A/V289D
mutants [50]. Two additional YXXU sequences were identiﬁed in
the Cx43 C-terminus, Y230VFF and Y265AYF, although the ﬁrst was
thought to be too close to the last transmembrane domain to be
a functional AP-2 binding region [51]. Mutation and deletion anal-
ysis of the Y265AYF and Y286KLV sites (referred to as S2 and S3,
respectively) revealed that mutating either site reduced the inter-
action of Cx43 with Dab2 and clathrin [51]. Mutating both sites
virtually completely abolished the interaction with Dab2 and its
colocalization [51]. These AP-2 binding mutants also exhibited
increased half-lives from 1 h for wild-type to 2 h for the single S2
or S3 mutants and 4 h for the double S2 + S3 mutant [51]. HeLa
cells expressing the single site mutants also had twice as manygap junction channels, while the double mutants had three times
as many as the wild-type Cx43 expressing cells [51]. In addition,
when the mutant-expressing cells were paired with the wild-type
Cx43-expressing cells, AGJs were more often internalized in the
wild-type Cx43 cells, with the double site mutant again exhibiting
a stronger effect [51]. Thus, these results indicated that the interac-
tion of AP-2 with the sorting signal YXXU motif of Cx43 at the
Y265AYF and Y286KLV sites mediates Cx43 internalization via CME.
Eps15 (epidermal growth factor (EGF) receptor substrate 15), a
protein that is involved in mediating EGF endocytosis and is found
at clathrin-coated pits, was also demonstrated to be involved in the
internalization of Cx43 [30,32]. Interestingly, while Cx43 ubiquiti-
nation was not found to be an absolute requirement for the prote-
asomal degradation of Cx43, it may have a role in Cx43
internalization. Eps15 and Cx43 interaction appeared to be depen-
dent on the ubiquitin interacting motif (UIM) of Eps15, as sug-
gested by the inability of an Eps15 mutant with a deletion of the
UIM to bind to Cx43. Furthermore, Cx43 colocalized with Eps15
at the plasma membrane of rat NRK cells. In addition to the
Eps15 UIM requirement for the interaction with Cx43, the ubiqui-
tination of Cx43 is also required. A previous study had demon-
strated that the E3 ubiquitin ligase, Nedd4, colocalized with Cx43
at the plasma membrane and interacted with Cx43 [52]. Nedd4
was also found to be required for Cx43 internalization, as the siRNA
knockdown of Nedd4 resulted in the accumulation of Cx43 in the
membrane and in gap junction plaques [52]. Nedd4 was subse-
quently demonstrated to be responsible for Cx43 ubiquitination
[30]. Knockdown of Nedd4 reduced the amount of ubiquitinated
Cx43, and also reduced the interaction of Cx43 and Eps15 [30].
The Cx43-interacting protein of 85 kDa (CIP85) was identiﬁed
by our laboratory to be a novel Cx43 binding partner, interacting
with the C-terminal domain of Cx43. Initial studies demonstrated
that CIP85 colocalized with Cx43 at the plasma membrane [53].
CIP85 was subsequently demonstrated to be involved in Cx43
internalization from the plasma membrane [54]. Overexpression
of CIP85 in HeLa cells increased the amount of internalized Cx43,
observed by both immunoﬂuorescence microscopy as well as
biochemically, by the reduction in the amount of TritonX-100-
insoluble Cx43 [54]. The TritonX-100-insoluble protein is consid-
ered to represent gap junction plaques, while TritonX-100-soluble
Cx43 represents protein that is intracellularly localized [39,55,56].
A direct interaction of CIP85 with Cx43 may be required for the
increased internalization, as this effect was not observed when a
non-interacting CIP85 truncation mutant was expressed instead
of wild-type [54]. Interestingly, CIP85 was also observed to interact
and colocalize with clathrin at the plasma membrane by coimmu-
noprecipitation and immunoﬂuorescence experiments [54]. The
nature of the CIP85 interaction with clathrin, however, is unclear.
For example, the coimmunoprecipitation did not indicate whether
CIP85 was directly binding to clathrin or if this occurs through an
adaptor protein. Also, the precise functional role of CIP85 in Cx43
internalization is currently unknown. We speculate that CIP85
might be involved in Cx43 CME, perhaps acting in the recruitment
of the clathrin machinery to Cx43 gap junction plaques. Further
studies of the interaction of CIP85 with the clathrin machinery,
as well as CIP85 loss-of-function studies on Cx43 CME internaliza-
tion studies will be required to address some of these issues.
3.3. Post-endocytic trafﬁcking of Cx43
After internalization, Cx43 is trafﬁcked intracellularly to differ-
ent destinations. Studies have demonstrated that internalized Cx43
can be degraded by the lysosome [15,21,44,49,56–63], but can also
be recycled to the membrane [33,41,48,61,64]. Ubiquitination is
thought to play an important role in the sorting of internalized
Cx43.
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plasma membrane localized Cx43 has been observed. Cellular
exposure to the phorbol ester TPA (12-O-tetradecanoylphorbol
13-acetate) or to EGF causes the internalization of Cx43 from the
plasma membrane, observed as decreased levels of membrane
localized Cx43. Cx43 ubiquitination was also detected after treat-
ment [31,34]. Both mono- and polyubiquitinated forms of Cx43
(detected with ubiquitin-speciﬁc antibodies) were observed
biochemically, particularly in response to TPA treatment [34].
Multi-monoubiquitinated Cx43 was also observed under normal
untreated conditions [30]. The ubiquitination of Cx43 in gap junc-
tion plaques was inferred in immunoelectron microscopy experi-
ments, where 50% of plaques were ubiquitinated when Cx43
trafﬁcking to the plasma membrane was blocked by brefeldin A
(BFA) treatment, demonstrating the presence of ubiquitin at the
plaques [65]. In addition, two E3 ubiquitin ligases, Nedd4 and
Smurf2 (smad ubiquitination regulatory factor-2), were identiﬁed
to affect cell surface Cx43 [52,66] and GJIC levels [66]. A third E3
ligase, TRIM21, was subsequently identiﬁed to interact with
Cx43, colocalizing at the cell surface where Cx43 phosphorylation
appeared to induce TRIM21-mediated Cx43 ubiquitination and
degradation [67].
Initial studies suggested that the proteasome was actively in-
volved in the turnover of Cx43 gap junctions. Many of these studies
came to this conclusion after utilizing general proteasomal inhibi-
tors which resulted in the accumulation of Cx43 at the plasma
membrane with increased amounts of gap junction plaques
[15,20,31,34,58,60,61,68–71]. The identiﬁcation of ubiquitinated
Cx43 further supported this idea because ubiquitination is known
to be a modiﬁcation that marks a substrate for proteasomal degra-
dation. However, a more recent study suggested otherwise. Utiliz-
ing the previously described lysine to arginine Cx43 mutant that
presumably is unable to be ubiquitinated, the mutant was still able
to be trafﬁcked through the secretory pathway to the plasma
membrane, form intact gap junctions, and participate in GJIC
(although at a lower level) [72]. Proteasomal inhibition again
revealed increased levels of membrane Cx43, although it was
discovered that the loss of Akt/protein kinase B proteasomal degra-
dation was primarily responsible for the stabilization of Cx43 [72].
Akt phosphorylation of Cx43 is responsible for the reduction of gap
junctional Cx43 [72]. Thus, it is more likely that other mechanisms,
such as lysosomal degradation, are responsible for the turnover of
Cx43 in gap junctions.
In addition to the Akt study, Cx43 has also been reported to be
monoubiquitinated [34]. This is signiﬁcant because while the K48
ubiquitin chain is generally believed to be a marker for proteaso-
mal degradation, monoubiquitination and also K63 polyubiquitina-
tion are more likely to be involved in other cellular processes, such
as protein internalization and trafﬁcking [73,74]. Importantly,
Cx43 interacts with components of the ESCRT (endosomal sorting
complex required for transport) machinery, speciﬁcally with
UIM-containing proteins, Hrs (hepatocyte growth factor-regulated
tyrosine kinase substrate) and Tsg101 (tumor susceptibility gene
101) [33,75]. The ESCRT machinery is responsible for the endo-
somal sorting of ubiquitinated membrane proteins (reviewed in
[76]) and consists of four ESCRT complexes, ESCRT-0, ESCRT-I, ESC-
RT-II, and ESCRT-III, which are composed of different subunits. Hrs
comprises the ESCRT-0 complex along with STAM (signal transduc-
ing adaptor molecule) and in human cells, ESCRT-0 associates with
Eps15b. ESCRT-0 acts to retain ubiquitinated membrane proteins
in the endosomal membrane. Tsg101 comprises the ESCRT-I com-
plex with three other proteins and the Tsg101 UEV (ubiquitin E2
variant) domain binds to ESCRT-0, mediating the recruitment of
ESCRT-I to the endosome. ESCRT-II is recruited to ESCRT-I, and
which then recruits the ESCRT-III complex. The ESCRT machinery
serves to sort ubiquitinated membrane proteins from theendosome into intraluminal vesicles which prevents recycling, ret-
rograde transport to the secretory pathway, or endosomal
retention.
Hrs and Tsg101 were found to mediate the intracellular trafﬁck-
ing of Cx43 from endosomes to lysosomes [33]. When combined
with both the TPA-stimulated internalization of Cx43 and a cyclo-
hexamide block in protein synthesis, knockdown of Hrs and
Tsg101 by siRNA increased the amount of Cx43 at the plasma
membrane as well as the level of GJIC. In addition, reduced Hrs
and Tsg101 levels produced an accumulation of ubiquitinated
Cx43. It was proposed that Hrs and Tsg101 were responsible for
directing Cx43 towards degradation instead of being recycled back
to the plasma membrane. Cx43 recycling was previously demon-
strated to occur during mitosis [41] and situations of cellular stress
[61]. These studies indicated that Cx43 may be subject to the
highly regulated ESCRT machinery which would direct ubiquitinat-
ed Cx43 towards degradation and allow non-ubiquitinated Cx43 to
be recycled back to the plasma membrane. Thus, Cx43 ubiquitina-
tion has a key role in determining the amount of Cx43 in gap junc-
tion plaques, and therefore, the level of GJIC.
In addition to the ubiquitin modiﬁcation, acetylation and
SUMOylation have also been demonstrated to affect Cx43 localiza-
tion and GJIC [77,78]. Cx43 acetylation in mouse hearts caused the
relocalization of Cx43 from the intercalated discs to lateral mem-
branes, an effect found in diseased hearts [77]. GJIC was also neg-
atively affected by Cx43 acetylation [77]. Modiﬁcation with the
ubiquitin-like small protein SUMO (small ubiquitin-related modi-
ﬁer) had the opposite effect of increasing GJIC, while also increas-
ing both the amount of Cx43 found at the plasma membrane at gap
junctions and intracellular Cx43 [78]. Acetylation and SUMOyla-
tion modiﬁcations also occur at lysine residues, thus, it is possible
that cross-talk between the pathways regulating ubiquitin, acetyl
group, and SUMO attachment regulates Cx43 localization, trafﬁck-
ing, and GJIC. Cx43 post-translational modiﬁcations are clearly
important in modulating Cx43 activities.
3.4. Degradation of internalized connexins
Once internalized, Cx43 gap junctions are likely to be destined
for degradation to reduce the level of Cx43 and thus, indirectly reg-
ulating the amount of GJIC. A multitude of studies have demon-
strated the involvement of lysosomal degradation in the turnover
of Cx43. Early electron microscopy studies identiﬁed structures
that resembled lysosomes fused with internalized AGJs and Cx43
[79–81]. Subsequent studies primarily used a variety of lysosomal
inhibitors which produced an accumulation of Cx43 in lysosomes
as well as an overall increase in the total amount of Cx43, and
blocked the degradation of cell surface Cx43 [15,21,44,49,56–63].
More recently, a number of reports detailed the role of autoph-
agy in Cx43 turnover. Autophagy, speciﬁcally macroautophagy, in-
volves the formation of a characteristic intracellular double
membrane autophagosome that fuses with the lysosome for the
degradation of its cargo that can include large structures and
organelles [82]. The Atg autophagy-related proteins are primarily
responsible for executing autophagy. The Atg1/13/17 complex as-
sists in the induction of autophagosome formation where vesicle
nucleation is mediated by Atg6 (mammalian Beclin-1)/14 and
Vps34/15, followed by vesicle elongation mediated by the Atg8
or Atg12 complexes. During autophagosome maturation, Atg8
(mammalian LC3 or microtubule-associated protein 1 light chain
3) is conjugated to phosphatidylethanolamine (Atg8-PE/LC3-II)
which stably associates with the autophagosomal vesicle [82].
The Atg proteins serve as useful markers of autophagosomes and
can also be used to inhibit or disrupt autophagy.
The possible involvement of autophagy in regulating connexin
or gap junctional levels was ﬁrst revealed with the observation of
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[81,83,84]. Electron microscopy also revealed the presence of
Cx43 in autophagosomal structures in the failing canine heart
myocardium [85]. In addition, Cx43-GFP, exogenously-expressed
in HeLa cells, colocalized with LC3 [85]. Induction of autophagy
by starvation also revealed the localization of Cx43 within auto-
phagosomes, observed as vesicles containing LC3 in the vesicular
membrane as well as a reduction in Cx43 levels [86]. Inhibition
of autophagy, either with a lysosomal inhibitor or by siRNA knock-
down of Atg5, prevented both this colocalization and the loss of
Cx43 [86]. Furthermore, Cx43 also colocalized with the ubiquitin-
binding protein p62, known to have a role in autophagy [86]. These
studies revealed a role for autophagy in Cx43 degradation,
although the pool of Cx43 targeted for autophagic degradation
had not been determined.
Two of the most recent autophagy studies demonstrated that
the pool of Cx43 in plasma membrane gap junction plaques is tar-
geted for degradation by autophagy [87,88]. In one study, using
Cx43-GFP expressing HeLa cells, the formation of AGJs in live cells
was studied [88]. These Cx43-GFP containing AGJs were found in
various stages of autophagosomal formation in ultrastructural
analyses. Cx43 speciﬁcally in AGJs also colocalized with autophag-
osomal markers, such as LC3 and p62. Inhibition of autophagy by
siRNA knockdown of multiple proteins required for the autophagic
process (Beclin-1/Atg6, LC3B, LAMP-2, p62) or the pharmacological
inhibition of autophagy (with 3-methyladenine (3MA), wortman-
nin, or Baﬁlomycin A1) resulted in a threefold increase of total lev-
els of exogenously-expressed Cx43-GFP/YFP over the siRNA control
treated cells and a signiﬁcant increase in cytoplasmic AGJs. Beclin-
1 and p62 knockdown was also observed to result in the reduction
of colocalization of AGJs and autophagosomes [88].
The second study conﬁrmed Cx43 autophagy and described the
role of ubiquitination in Cx43 autophagy [87]. Using mouse liver
tissue, immunogold staining revealed the presence of Cx43 in auto-
phagic compartments (lysosomes, autophagosomes, autophago-
lysosomes). Under starvation conditions to stimulate autophagy,
an enrichment of Cx43 was found in the autophagic compartments,
as well as an increase in intracellular vesicles positive for Cx43, and
LC3 or p62. Starvation-induced autophagy also decreased the
amount of Cx43 at the plasma membrane, decreasing the half-life
of gap junctional Cx43 from 6 h to 3 h. The effects of starvation
were reduced or prevented by inhibitors of autophagy, with either
pharmacologic treatment with 3MA or lysosomal inhibitors, chlo-
roquine, ammonium chloride, leupeptin or genetically with Atg7
knockdown or using Atg5 null mouse embryonic ﬁbroblasts or
MEFs. Signiﬁcantly, 3MA or chloroquine treatment of starved cells
increased the amount of TritonX-100 insoluble (i.e. gap junctional)
Cx43, indicating that blocking autophagy speciﬁcally prevented
the loss of Cx43 at the plasma membrane. Furthermore, a combina-
tion of 3MA treatment with either Atg7 knockdown or using the
Atg5 null MEFs had no additive effect, demonstrating that it was
indeed autophagy that was being affected. Internalization and
lysosomal degradation of Cx43 (induced by lindane or c-hexachlo-
rocyclohexane treatment [57,89]) was also reduced when autoph-
agy was inhibited (both pharmacologically and genetically). To
further assess the relationship between autophagy and Cx43 inter-
nalization, the study utilized the previously described Cx43 Y286A
endocytosis mutant [32,49]. Both induction (by starvation or phar-
macologically with rapamycin treatment) and inhibition of
autophagy (via Atg7 knockdown) had no effect on the Y286A mu-
tant, which remained at the plasma membrane. This suggested a
dependence of Cx43 gap junctional autophagic degradation on
endocytosis. The role of Cx43 ubiquitination was also assessed.
Starvation conditions led to increased Cx43 ubiquitination. Nedd4
had been demonstrated to ubiquitinate plasma membrane local-
ized Cx43. Depletion of Nedd4 by siRNA knockdown also blockedthe starvation induced Cx43 degradation, indicating that Cx43
ubiquitination mediated by Nedd4 was required for the autophagic
degradation. Autophagy inhibition did not affect Cx43 ubiquitina-
tion, however, suggesting that the incorporation of Cx43 gap junc-
tions into autophagosomes occurred after ubiquitination. To
conﬁrm that Cx43 ubiquitination was required for autophagy, the
study utilized a Cx43-ubiquitin (Cx43-Ub) fusion protein. Nedd4
knockdown had no effect on this protein since it was already ubiq-
uitinated, while 3MA treatment or Atg7 knockdown to block
autophagy prevented Cx43-Ub internalization and localization in
autophagy compartments, conﬁrming the positive relationship be-
tween Cx43 ubiquitination and autophagy. Similar to the other
studies, Cx43 colocalized and coimmunoprecipitated with p62,
with an increased interaction observed upon starvation. Nedd4
depletion reduced the Cx43-p62 interaction, while the Cx43-Ub
protein had signiﬁcantly more interaction with p62. Since p62 con-
tains the UBA ubiquitin-binding domain, the interaction between
Cx43 and p62, and thus, Cx43 association with autophagosomes,
could rely on the binding of a Cx43 ubiquitin modiﬁcation with
the p62 UBA domain. The role of Eps15, already demonstrated to
be involved in the internalization of ubiquitinated Cx43 [30,32],
in Cx43 autophagy was also explored. The induction of autophagy
promoted the interaction of Cx43 with Eps15, which facilitated the
endocytosis of ubiquitinated Cx43, although it appeared that this
event occurred prior to the recruitment of autophagic proteins.
However, the inhibition of autophagy did not have a signiﬁcant ef-
fect on the high level of Cx43-Eps15 interaction. Reduction of
Eps15 by siRNA knockdown inhibited the starvation-induced
Cx43 degradation. Further analysis of the Eps15-Cx43 interaction
conﬁrmed that Cx43 ubiquitination was required for Eps15 binding
as Nedd4 knockdown prevented the Eps15-Cx43 interaction and
Eps15 failed to interact with the Cx43 Y286A mutant. The PY motif
containing the Y286 residue was previously demonstrated to be
involved in Nedd4 interaction [52]. Interestingly, the study also
demonstrated that Eps15 could interact with LC3, but not p62, sug-
gesting that Eps15 is an intermediate adaptor molecule which
bridges ubiquitinated Cx43 to the autophagic machinery. This
would also provide a mechanism to link the internalization of
ubiquitinated Cx43 with the autophagy degradation pathway.
The effect of 3MA inhibition of autophagy on GJIC in NIH3T3 cells
was also studied under both normal and starvation conditions,
where, GJIC (measured by dye transfer) was increased by 3MA
treatment, which was further enhanced by starvation [87].
Recent reports on the involvement of autophagy in Cx43 gap
junction turnover provides new information on the possible mech-
anisms that regulate the levels of Cx43 at the plasma membrane
and Cx43 channel activity. Previous reports detailing Cx43 lyso-
somal degradation, for the most part, assumed that the lysosome
was the end point for endo/lysosomal degradation, which is the
pathway that utilizes classical endocytic mechanisms (early, late
endosomes) and ending with proteins degraded by the lysosome.
However, these studies did not attempt to distinguish between
endo/lysosomal degradation and autophagy (phago/lysosomal).
Lysosomal inhibitors are known to block both pathways of
degradation, which would not allow the distinction of the different
pathways. Thus, it is possibly that the results of earlier studies
included effects from the inhibition of autophagosomal degrada-
tion. Lysosomal degradation of Cx43 gap junctions, either via the
endo/lysosome or autophagy, has been demonstrated to directly
affect GJIC [33,87]. Therefore, it is vital to fully elucidate the
processes regulating Cx43 lysosomal degradation. Based on these
reports, we speculate on two distinct possibilities for the internal-
ization, trafﬁcking, and degradation of Cx43 gap junctions by either
endosomes/lysosomes or autophagosomes.
In an endo/lysosomal model (Fig. 2), Cx43 trafﬁcs to the cell
surface and becomes ubiquitinated in a process mediated by the
Fig. 2. Model for the endo/lysosomal degradation of gap junctional Cx43. Cx43 assembled into connexons in gap junction plaques are ubiquitinated by the Nedd4 E3 ligase,
which then interact with Eps15. AP-2 binds to the cytoplasmic C-terminal domain of Cx43 and recruits the clathrin machinery. Cx43 plaques are internalized as double-
membrane annular gap junctions (1). The ESCRT-0 subunit Hrs binds to ubiquitinated Cx43 and sorts it through the endocytic pathway (2) to be degraded by the lysosome (3).
Non-ubiquitinated Cx43 is recycled back to the plasma membrane (4).
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Eps15. Perhaps in a complex with Eps15, Cx43 is also recognized
by AP-2 through its C-terminal YXXU motifs, which then recruits
the clathrin machinery (i.e. clathrin, Dab2, Dyn2) to the membrane.
Cx43 gap junctions are then endocytosed as AGJs. Once internal-
ized, the ubiquitinated Cx43 is recognized by the UIM of Hrs in
the ESCRT-0 complex. Through the ESCRT machinery, ubiquitinat-
ed Cx43 is sorted through the endosomal pathway, moving from
early endosomes to late endosomes to lysosomes where Cx43 is
then degraded. Non-ubiquitinated Cx43 is not retained in the
endosomal membrane by the ESCRT machinery, and is therefore
available to be recycled back to the plasma membrane.
In a model for autophagy (Fig. 3), Eps15 is recruited to ubiqui-
tinated Cx43 gap junctions that are assembling into clathrin-
coated pits when autophagy is induced (for example, under
starvation conditions). Then, either during or immediately after
vesicle formation, Eps15 begins to recruit the autophagic machin-
ery to the AGJs, perhaps recruiting LC3 which then recruits other
autophagy-related proteins such as p62. Autophagosomes form
around AGJs, fuse with the lysosome to form the autophagolyso-
some where its contents (i.e. the AGJs) are degraded.
While progress has been made in elucidating the mechanisms
and pathways that contribute to the downregulation of GJIC via
Cx43 gap junction levels, there are many questions that remain
unanswered and gaps to be closed in current models. One major
question is how do the CME, endo/lysosomal, and autophagosomal
pathways interact to facilitate the internalization, trafﬁcking,degradation, and recycling of Cx43? And, speciﬁcally, which signals
determine the destinations that Cx43 is trafﬁcked to after internal-
ization and what is the role(s) that Cx43 binding proteins, such as
CIP85, play in the internalization and degradation of Cx43?
Another question focuses on the interaction of Cx43 with AP-2,
which has been implicated in Cx43 CME, and with Eps15,
which is involved in Cx43 internalization. It would be enlighten-
ing to study both of these proteins and the mechanism(s) that
determines how these pathways might intersect to mediate Cx43
internalization. Ubiquitination and ubiquitin-binding proteins
(e.g. Eps15) are clearly involved in the internalization process,
but, what determines whether Cx43 gap junctions are ubiquitinat-
ed or not? Furthermore, what is the fate of non-ubiquitinated
Cx43? Cx43 ubiquitination does not appear to be required for GJIC
since non-ubiquitinated Cx43 can still trafﬁc to the plasma mem-
brane and participate in GJIC [72], although the loss of Nedd4-
mediated Cx43 ubiquitination diminishes the internalization of
Cx43 from the plasma membrane [30,52]. It is clear that Cx43-
interacting proteins have a major role in regulating Cx43 trafﬁck-
ing and turnover. It will be of great interest to determine if
these proteins can affect the interaction of Cx43 with other binding
partners, and possibly, alter the fate of Cx43.
4. Human diseases
Given that gap junctions interconnect cells in solid tissues,
connexins and GJIC provide the mechanism for the exchange of
Fig. 3. Model for the autophagosomal degradation of gap junctional Cx43. Ubiquitinated Cx43 assembled into connexons in gap junction plaques are recognized by Eps15
during or after the internalization of the plaque into annular gap junctions via clathrin-mediated endocytosis (1). Eps15 interacts with LC3 which recruits other autophagic
proteins to induce the formation of an autophagosome around the annular gap junction (2). The autophagosome fuses with the lysosome (3) resulting in the degradation of
the autophagolysosome contents (4).
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composition of connexins in various tissues and cell types can dif-
fer widely. With 21 different human connexins, there is still much
to understand about how they interact with one another and how
they are regulated in terms of cellular levels, channel activity, sub-
cellular localization, and degradation. These processes are impor-
tant because mutations in different connexin genes have been
identiﬁed in human diseases arising in different tissues where
there may be the differential expression of more than one connex-
in. For example, in the cardiovascular system, Cx40, Cx43, and
Cx45 are expressed, and these gap junctions facilitate the propaga-
tion of the action potentials responsible for the rhythmic contrac-
tion of the heart [2]. These connexins are expressed differentially,
however, with Cx43 in the ventricular myocardium, and all three
in atrial cardiomyocytes. Gap junctions are normally localized to
the intercalated disks in heart tissue [2]. A reduction in Cx43
expression and relocalization of Cx43 to lateral membranes has
been found in arrhythmias and under conditions of abnormal im-
pulse conduction [7–9]. A reduction in the expression of Cx43
has also been observed in myocardial infarctions [7–9]. The impor-
tance of Cx43 in heart disease has been demonstrated with the use
of certain experimental therapies, for example the use of rotigap-
tide, which enhances GJIC, and gap26, a Cx43 structural mimetic
peptide (ﬁrst extracellular loop), which protects against ischemicinjury [90]. Cx40 also appears to be critical in heart function, as
Cx40 mutations have been identiﬁed in patients with atrial ﬁbrilla-
tion [91,92].
While the effects of altered GJIC are evident in the heart, conn-
exin alterations are also found in other tissues and diseases that
are not clearly GJIC-dependent. Connexins have been implicated
in human cancers. The downregulation of connexins at the plasma
membrane has been observed in human and mouse breast cancer
and rat glioma cells [59,80,93], while Cx43 overexpression reduced
proliferation and tumorigenesis [80]. Given that undocked hemi-
channels can affect cell growth and migration [94,95], the role of
connexins in cancer may be due to hemichannel or gap junction
activities, or possibly, a combination of both types of channels.
Cx43 mutations that affect its trafﬁcking and localization have also
been found in the human developmental disease, oculodentodigi-
tal dysplasia [10,96]. Cx32 mutations (e.g. E208K that exhibits traf-
ﬁcking defects and elevated proteasomal degradation) have been
identiﬁed in the human neurological disorder Charcot–Marie–
Tooth disease (CMTx) [97]. Lastly, Cx50 mutations linked to
hereditary congenital cataracts are defective in trafﬁcking and pro-
teasomal degradation [98,99].
The trafﬁcking and degradation of connexins is clearly impor-
tant in a number of human diseases. Thus, proper regulation of
these processes has important consequences for the pathways
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gap junctions.
5. Conclusion
While much progress has been made toward elucidating the
mechanisms and pathways that regulate connexin trafﬁcking,
localization, and degradation (i.e. the connexin life cycle), more
questions remain about these critical events. Experimental
systems are evolving as evidenced by some of the recent studies
detailed here. However, future studies are necessary to determine
how proteasomal degradation affects connexin functions, and
whether lysosomal degradation consists of multiple divergent
pathways. It will also be necessary to determine whether these
mechanisms affect other connexins and whether these are general
connexin regulatory pathways or speciﬁc to only certain connex-
ins, particularly as more connexin mutations are identiﬁed in
different human diseases. For example, although autophagy has
also been implicated in Cx50 [86], Cx26, and Cx32 [87] degrada-
tion, at this time, knowledge of these connexins is not as extensive
or as detailed as known for Cx43. Knowledge of the factors and
signals that contribute to the proper trafﬁcking of connexins and
the regulation of connexin levels will aid in the understanding of
connexin-related disease pathologies, and perhaps in the future,
contribute to the treatment of human disease arising from connex-
in abnormalities.
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